This publicly available dataset namely PHE-SICH-CT-IDS, which is constructed 120 CT scans of patients with spontaneous intracerebral hemorrhage. PHE-SICH-CT-IDS contains 3,511 CT images of SICH occurring in the basal ganglia region, with associated labels for the surrounding edematous zone around the hematoma. PHE-SICH-CT-IDS provides multiple functionalities including segmentation, detection, feature extraction, and more. It is divided into three sub-datasets representing different functionalities and formats: subdatasetA in NIfTI format, containing source CT data and edema zone labels, offering segmentation, feature extraction and prognosis prediction functionalities; subdatasetB and subdatasetC in JPG and PNG formats, containing sliced data with segmentation labels and detection annotations, providing segmentation and detection functionalities.

This guidance update reflects changes made to the required data elements for reporting as well as the cadence with which these elements need to be reported to CDC’s National Healthcare Safety Network (NHSN) following the expiration of the federal COVID-19 public health emergency declaration. There are no significant changes or additions to the reporting questions as a result of this guidance update. Information on reporting to NHSN can be found here: https://www.cdc.gov/nhsn/covid19/hospital-reporting.html.

This page, "val-phe", is part of the NIST Chemistry WebBook. This site and its contents are part of the NIST Standard Reference Data Program.

The main entity of this document is a entry with accession number PF02812

The eCommerce activity of PHE, Inc. amounted to US$318m in 2024. Learn more about their online business including detailed eCommerce revenue analytics.

KPI's for the performance Total rural population with access to safe drinking water Total number of samples collected for water quality test in the District during the reporting month Total Number of new sanitation schemes completed till date in CFY Total Number of new water supply schemes completed till date CFY Total number of existing functional PHE tube-wells Total amount of revenue collected till date in current financial year Total number of water pipeline repaired in the District during the reporting month

Subscribers can find out export and import data of 23 countries by HS code or product’s name. This demo is helpful for market analysis.

This dataset tracks the updates made on the dataset "COVID Hospital Data Reporting Guidance Post-PHE" as a repository for previous versions of the data and metadata.

Ac-Phe-Oet Market Outlook

The global Ac-Phe-Oet market size was estimated to be USD 245.3 million in 2023 and is projected to reach USD 428.5 million by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. This growth can be attributed to the increased demand for Ac-Phe-Oet in various pharmaceutical and chemical synthesis applications, alongside advancements in research and development activities aimed at discovering novel therapeutic applications.

One of the primary growth factors driving the Ac-Phe-Oet market is the surge in pharmaceutical research activities. The pharmaceutical industry is continually seeking new compounds and intermediates for drug development, and Ac-Phe-Oet has emerged as a crucial component in this quest. Its role as a building block in peptide synthesis makes it indispensable for designing new therapeutic agents, thereby fueling its market growth. Additionally, the increasing incidence of chronic diseases globally is pushing pharmaceutical companies to invest heavily in R&D, further amplifying the demand for Ac-Phe-Oet.

Another significant growth factor is the expanding research and development sector. Research institutions and universities across the globe are focusing on exploring the potential applications of Ac-Phe-Oet. Foundational research into the biochemistry of peptides and their analogs is crucial for developing innovative treatments for a range of diseases. Government grants and funding from private organizations aimed at promoting scientific discoveries are also contributing to the increasing demand for this compound.

The chemical synthesis industry also plays a vital role in driving the market for Ac-Phe-Oet. This compound is extensively used as an intermediate in the synthesis of various chemical products. The growing chemical industry, especially in developing countries, is contributing to the increased demand for high-purity Ac-Phe-Oet for the manufacturing of specialty chemicals and materials. The compound’s versatility and effectiveness in chemical synthesis make it a valuable asset in this industry.

From a regional perspective, the Asia Pacific region is expected to witness the highest growth in the Ac-Phe-Oet market. This can be attributed to the region’s booming pharmaceutical and chemical industries, supported by favorable government policies and increasing foreign investments. North America and Europe are also significant markets due to their advanced research infrastructure and the presence of leading pharmaceutical companies. However, markets in regions like Latin America and the Middle East & Africa are anticipated to grow at a steady pace, driven by gradual industrialization and expanding research activities.

Product Type Analysis

The Ac-Phe-Oet market is segmented by product type into two categories: Purity ≥ 98% and Purity < 98%. The Purity ≥ 98% segment is expected to dominate the market during the forecast period. This can be attributed to the high demand for superior quality compounds in pharmaceutical and research applications. High-purity Ac-Phe-Oet ensures better efficacy and safety in drug development processes, which is a crucial requirement for pharmaceutical companies. Consequently, this segment is anticipated to witness significant growth, driven by the stringent quality standards in the pharmaceutical sector.

The Purity < 98% segment, while smaller in comparison, also holds a substantial share of the market. This product type is typically used in applications where ultra-high purity is not a critical requirement, such as certain chemical synthesis processes. The cost-effectiveness of lower purity Ac-Phe-Oet makes it an attractive choice for chemical companies looking to optimize production costs without compromising the quality of their end products. As the chemical manufacturing sector continues to expand, this segment is expected to maintain a steady growth trajectory.

Demand for high-purity Ac-Phe-Oet is particularly strong in developed regions such as North America and Europe, where stringent regulatory standards necessitate the use of high-quality intermediates in pharmaceutical manufacturing. In contrast, the Purity < 98% segment finds more significant uptake in developing regions where cost considerations play a more pivotal role in procurement decisions. The market dynamics between these two product type segments highlight the diverse requirements and strategic decisions of end-users across different regions.

The increasing focus on precision medic

Extracellular PM20D1 (N-fatty-acyl-amino acid synthase/hydrolase PM20D1) catalyzes the reversible condensation of L-phenylalanine (L-phe) and oleate ((9Z)-octadecenoate) to form oleoyl-phe (N-(9Z-octadecenoyl)-L-phenylalanine) and water. In addition to the condensation of phe with oleate ((9Z)-octadecenoate) annotated here, purified human PM20D1 protein in vitro can catalyze the condensation of leucine and isoleucine with oleate and with other long-chain unsaturated fatty acids including arachidonate, with lower efficiencies. Although the reverse (hydrolysis) direction of this reaction is thermodynamically favored, expression of PM20D1 protein in mice or in cultured cells was associated with elevated levels of oleoyl-phe in serum and culture media, respectively. Treatment of cultured mouse brown adipose tissue adipocytes and of isolated mitochondria with oleoyl-phe induced uncoupled respiration independently of UCP1 (uncoupling protein 1). Photolabeling studies of isolated mitochondria identified the ADP/ATP symporters SLC25A4 and SLC25A5 as possible targets of oleoyl-phe. Consistent with these observations, expression of PM20D1 and elevated blood levels of oleoyl-phe in mice were associated with increased energy expenditure and improved glucose homeostasis. These results suggest a physiological role for PM20D1 and its condensation reaction product in thermogenesis and raise the possibility that oleoyl-phe and related molecules might have a clinical role in treatment of obesity (Long et al. 2016).

Fmoc Phe 3 I Oh Reagent Market Outlook

The global Fmoc Phe 3 I Oh Reagent market size was valued at approximately USD 150 million in 2023 and is expected to escalate to around USD 290 million by 2032, growing at a compound annual growth rate (CAGR) of 7.2% over the forecast period. The market growth is significantly driven by advancements in pharmaceutical and biotechnological research, which continue to expand the applicability of specialized reagents such as Fmoc Phe 3 I Oh.

The pharmaceutical industry's relentless pursuit of novel drug discovery and development is a major growth factor for the Fmoc Phe 3 I Oh Reagent market. With increasing investments in healthcare and the rising prevalence of chronic diseases, there is a surging demand for advanced reagents that facilitate complex peptide synthesis. Fmoc Phe 3 I Oh Reagent, with its high specificity and efficiency, plays a crucial role in the synthesis of peptides, which are essential components in the development of new therapeutic drugs.

Another pivotal factor contributing to the market's growth is the expanding scope of biotechnological research. Biotechnology companies are constantly exploring new biological pathways and mechanisms, often requiring sophisticated reagents for their experiments. The unique properties of Fmoc Phe 3 I Oh Reagent make it an indispensable tool in these endeavors. As biotechnological innovations continue to rise, so does the demand for high-purity reagents, further propelling market growth.

In addition to pharmaceuticals and biotechnology, chemical research is a significant domain driving the Fmoc Phe 3 I Oh Reagent market. Chemical synthesis, both in academic settings and industrial applications, increasingly relies on high-quality reagents to achieve precision and repeatability. This growing reliance on specialized reagents in cutting-edge research projects underscores the reagent's vital role and contributes to the market's robust growth trajectory.

High Pure Peptides are increasingly becoming a cornerstone in the development of advanced pharmaceuticals and biotechnological applications. These peptides, characterized by their exceptional purity and specificity, are essential in the synthesis of complex therapeutic compounds. The demand for High Pure Peptides is driven by their ability to ensure the accuracy and reliability of experimental outcomes, which is critical in drug discovery and development processes. As the pharmaceutical industry continues to evolve, the need for high-quality, pure peptides is more pronounced, supporting the creation of innovative therapies that address a wide range of medical conditions. This growing demand underscores the importance of High Pure Peptides in the broader context of pharmaceutical and biotechnological research.

The regional outlook for the Fmoc Phe 3 I Oh Reagent market is diverse, reflecting varying levels of industrialization, research capabilities, and healthcare investment. North America, with its advanced pharmaceutical and biotechnology sectors, holds a significant share of the market. Europe follows closely, driven by strong research initiatives and robust healthcare infrastructure. The Asia Pacific region is poised for rapid growth, fueled by rising investments in biotechnology and pharmaceuticals, along with increasing support from government initiatives. Latin America and the Middle East & Africa are also expected to exhibit steady growth, albeit at a slower pace, as they gradually enhance their research and healthcare capabilities.

Product Type Analysis

The Fmoc Phe 3 I Oh Reagent market, segmented by product type, encompasses two primary categories: products with purity ? 98% and those with purity < 98%. Reagents with a purity of ? 98% dominate the market, reflecting their widespread use in high-precision applications. These high-purity reagents are essential in pharmaceutical and biotechnological research, where the margin for error is minimal. The demand for high-purity reagents is bolstered by the need for reproducible and accurate results in scientific studies, which are crucial for the development of new drugs and biotechnological applications.

On the other hand, reagents with a purity of < 98% cater to less stringent applications, often in preliminary research stages or less critical industrial processes. While these reagents are not as highly demanded as their higher-purity counterparts, they still hold a significant market sha

The joint PHE-BGS digital radon potential dataset provides the current definitive map of radon Affected Areas in England and Wales. It will also allow an estimate to be made of the probability that an individual property in England and Wales is at or above the Action Level for radon. This information also provides an answer to one of the standard legal enquiries on house purchase in England and Wales, known as CON29 standard Enquiry of Local Authority; 3.13 Radon Gas: Location of the Property in a Radon Affected Area. The radon potential dataset will also provide information on the level of protection required for new buildings under as described in the latest Building Research Establishment guidance on radon protective measures for new buildings (BR 211 2007). This radon potential hazard information for England and Wales is based on Public Health England (PHE) indoor radon measurements and BGS digital geology information. This product was derived from DigMap50 V3.14 and PHE in-house radon measurement data. The indoor radon data is used with the agreement of the PHE. Confidentiality of measurement locations is maintained through data management practices. Access to the data is restricted. This dataset has been superseded by PHE-BGS Joint Radon Potential Dataset For Great Britain. Radon is a natural radioactive gas, which enters buildings from the ground. Exposure to high concentrations increases the risk of lung cancer. The Health Protection Agency recommends that radon levels should be reduced in homes where the annual average is at or above 200 becquerels per cubic metre (200 Bq m-3). This is termed the Action Level. The Health Protection Agency defines radon Affected Areas as those with 1% chance or more of a house having a radon concentration at or above the Action Level of 200 Bq m-3. The dataset was originally developed by BGS with the Health Protection Agency (HPA) which is now part of Public Health England.

Lab-confirmed case counts for England and subnational areas are provided by Public Health England and Office for National Statistics data © Crown copyright and database right 2020. All data on deaths and data for the rest of the UK are provided by the Department of Health and Social Care based on data from NHS England and the devolved administrations. This data is sourced from the UK governments Coronavirus dashboard, and thanks to code developed by Esri UK, the service will refresh when the governments dashboard is updated.To read more information such as the data collection and specific sourced, take a look at the data from the .gov.uk website here

Subscribers can find out export and import data of 23 countries by HS code or product’s name. This demo is helpful for market analysis.

Subscribers can find out export and import data of 23 countries by HS code or product’s name. This demo is helpful for market analysis.